CCL18 Is an IL-6 Responsive Biomarker in Systemic Sclerosis Associated Interstitial Lung Disease-Analysis from Phase 3 Trial of Tocilizumab
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要